Device Week, April 5, 2019 – A Trio Of FDA Guidance Docs To Keep An Eye On
Executive Summary
In this week’s podcast, Medtech Insight journalists Shawn M. Schmitt, Ferdous Al-Faruque and Elizabeth Orr discuss a recent flurry of guidance document news from US FDA on facility inspections, artificial intelligence and anthrax detection devices.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode:
-
With Fresh Guidance, US FDA Aims For Consistency In Device Facility Inspections
-
Rise Of The Machines: FDA Artificial Intelligence Guidance Is Coming
- After Years Of Waiting, FDA Classifies Anthrax Detection Devices As Class II